Skip to Main Content

Author Details

Barbara Bachtiary
Center for Proton Therapy, Paul Scherrer Institute
2000
39
16
PMIDPaper TitleJournal TitlePublished Year
37913953Treatment planning comparison for head and neck cancer between photon, proton, and combined proton-photon therapy - From a fixed beam line to an arc.Radiother Oncol2024
38067202Financial Toxicity in Swiss Cancer Patients Treated with Proton Therapy: An Observational Cross-Sectional Study on Self-Reported Outcome.Cancers (Basel)2023
38075481Pencil Beam Scanning Proton Therapy for Adolescents and Young Adults with Head and Neck Sarcomas.Int J Part Ther2023
36010847Hearing Loss in Cancer Patients with Skull Base Tumors Undergoing Pencil Beam Scanning Proton Therapy: A Retrospective Cohort Study.Cancers (Basel)2022
35832560Clinical Outcome After Pencil Beam Scanning Proton Therapy of Patients With Non-Metastatic Malignant and Benign Peripheral Nerve Sheath Tumors.Front Oncol2022
36052578Quality-of-life evaluations in children and adolescents with Ewing sarcoma treated with pencil-beam-scanning proton therapy.Pediatr Blood Cancer2022
34340918Clinical Outcome of Sacral Chordoma Patients Treated with Pencil Beam Scanning Proton Therapy.Clin Oncol (R Coll Radiol)2021
34638375A Prospective Study on Health-Related Quality of Life and Patient-Reported Outcomes in Adult Brain Tumor Patients Treated with Pencil Beam Scanning Proton Therapy.Cancers (Basel)2021
30943055Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomas.Br J Radiol2020
32081577Pencil Beam Scanning Proton Therapy for Paediatric Neuroblastoma with Motion Mitigation Strategy for Moving Target Volumes.Clin Oncol (R Coll Radiol)2020
32881313Outcomes of adolescents and young adults treated for brain and skull base tumors with pencil beam scanning proton therapy.Pediatr Blood Cancer2020
32413727Clinical outcomes of head and neck adenoid cystic carcinoma patients treated with pencil beam-scanning proton therapy.Oral Oncol2020
32375820Prognostic impact of the "Sekhar grading system for cranial Chordomas" in patients treated with pencil beam scanning proton therapy: an institutional analysis.Radiat Oncol2020
32222414Outcomes, Prognostic Factors and Salvage Treatment for Recurrent Chordoma After Pencil Beam Scanning Proton Therapy at the Paul Scherrer Institute.Clin Oncol (R Coll Radiol)2020
31322969Radiation-induced optic neuropathy after pencil beam scanning proton therapy for skull-base and head and neck tumours.Br J Radiol2020
31067074Proton therapy for brain tumours in the area of evidence-based medicine.Br J Radiol2020
29194976The effect of adjuvant radiotherapy on radial forearm free flap volume after soft palate reconstruction in 13 patients.Clin Otolaryngol2018
30021697Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy.Radiother Oncol2018
28764925Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire.Radiother Oncol2017
28204968A 5â¿¿year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria.Wien Klin Wochenschr2017
28627000Pencil beam scanned protons for the treatment of patients with Ewing sarcoma.Pediatr Blood Cancer2017
22981499Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.Eur J Cancer2013
23668170[With proton scanning multiple exposures are safe].MMW Fortschr Med2013
21448626Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced.Wien Klin Wochenschr2011
21603990Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab.Strahlenther Onkol2011
20561694Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses.Radiother Oncol2010
20831481Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.Acta Oncol2010
165163163D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up.Radiother Oncol2006
17020965Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity.Clin Cancer Res2006
16024181Comparison of late toxicity between continuous low-dose-rate and pulsed-dose-rate brachytherapy in cervical cancer patients.Int J Radiat Oncol Biol Phys2005
16334159Impact of radiotherapy with and without concurrent cisplatin on lymphocyte subpopulations in cervical cancer patients.Anticancer Res2005
12796391Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.Clin Cancer Res2003
11943739KAI1 metastasis suppressor protein in cervical cancer.Am J Pathol2002
12397642Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer.Int J Cancer2002
11888674Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival.Cancer Lett2002
11146234Impact of human papillomavirus infection on the expression of the KAI1 metastasis suppressor protein in invasive cervical cancer.Cancer Lett2001
11550164Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results.Cancer2001
11455003Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions.Mod Pathol2001
11205303The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer.Anticancer Res2000
  • 1 - 39 of 39

Recommended Authors

Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 1
Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 1
Melvin L K Chua
National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 4
Daniel J Ma
Mayo Clinic
Career Start Year 2005
Number of shared co-authors 1
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2004
Number of shared co-authors 5
Daniel S Higginson
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 5
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 1
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Anuja Jhingran
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 1
Nancy Y Lee
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 1
Beth M Beadle
Stanford University
Career Start Year 1999
Number of shared co-authors 0
Frank J P Hoebers
Maastricht University Medical Centre
Career Start Year 1999
Number of shared co-authors 1
Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Coen R N Rasch
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 0
John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 7
Philippe Lambin
Maastricht University
Career Start Year 1992
Number of shared co-authors 4
Philippe Maingon
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Career Start Year 1988
Number of shared co-authors 1
Robert L Foote
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 1
Danielle Van den Weyngaert
University of Antwerp
Career Start Year 1987
Number of shared co-authors 0
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 1
Johannes H A M Kaanders
Radboud University Medical Center
Career Start Year 1987
Number of shared co-authors 1
David G Pfister
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 1
David I Rosenthal
MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
Silvia C Formenti
Weill Cornell Medical College
Career Start Year 1986
Number of shared co-authors 1
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 1
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 1982
Number of shared co-authors 9
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0
Catharine M L West
University of Manchester
Career Start Year 1981
Number of shared co-authors 1

Collaborators

Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Anthony Fyles
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Jian-Hua Li
th Hospital
Co-authored papers 1
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
Johannes A Hainfellner
Medical University of Vienna
Co-authored papers 1
Linda Z Penn
University of Toronto
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Igor Jurisica
Schroeder Arthritis Institute
Co-authored papers 1
Carlo Bastianutto
University of Toronto
Co-authored papers 1
Joerg Schwock
University of Toronto
Co-authored papers 1
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Co-authored papers 1
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Wendy Zhang
University of Texas at San Antonio
Co-authored papers 1
Release 1.2